Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Co

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Co

Item

http://www.wikidata.org/entity/Q34640536

Q34640536

about

Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.TOP2A gene copy number change in breast cancer.Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy.Dual-colour CISH is a reliable alternative to FISH for assessment of topoisomerase 2-alpha amplification in breast carcinomas.miR-34a expression in human breast cancer is associated with drug resistance.Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.Copy number variation and high expression of DNA topoisomerase II alpha predict worse prognosis of cancer: a meta-analysis.Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

P2860

Q34010867-2F4A2CA2-FFA2-4236-9CA1-5D48A406A900 Q35491733-CCA0F1C6-7B04-4563-B2DF-709E8F4027BA Q36151341-385DF848-F096-45E5-8423-2CF6C400CB82 Q36671427-3E5C01AA-F68E-4495-82BC-F484CF180C70 Q36907273-CFB874FE-C19F-4A39-85DC-064F70892D72 Q37638287-A2658C44-67A3-4681-8261-BB55DB4AB7B5 Q37716023-A84400CD-DA29-4B8F-A2B7-0C6DE58A6D82 Q38591976-C1F26A93-BD44-4602-A92C-10870642E275 Q38669870-603C09DE-FDE6-474F-99E1-963960D2D4C9 Q38699879-7525D6C5-206A-401B-8989-913E7881BDAC Q44358325-B1BE1546-64FD-4926-B405-6D7F2284D1FA Q47139724-AE5C9DF8-CAA9-4666-A2EA-13D2136D45D5 Q47160829-45967DE8-9006-4963-99F2-6447DCD69450 Q55066764-FFA35269-D881-4F32-8DBA-CF4C485063BD Q55396428-56D9D875-0CED-4000-9930-D4C9D142E9DA Q57152794-D529A459-901D-4C89-A32F-92991A793DDD

P2860

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Co

Item

http://www.wikidata.org/entity/Q34640536

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu